Purple Biotech (PPBT) Change in Account Payables (2017 - 2026)
Purple Biotech's (PPBT) quarterly Change in Account Payables came in at -$1.2 million in Q1 2026, down 109.97% year-on-year from $12.5 million in Q1 2025, and down 196.13% on a QoQ basis from $1.3 million in Q4 2025.
Purple Biotech (PPBT) Change in Account Payables (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 109.97% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was -$201000.0, a 92.33% increase from a year earlier, with the FY2025 full-year figure at $450000.0, up 121.68% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.2 million, down from $1.3 million in the prior quarter.
- Over the last five years, Change in Account Payables for PPBT reached as high as $1.6 million in Q3 2022 and fell as low as -$1.2 million in Q1 2026.
- Historically, Change in Account Payables has averaged -$43294.1 across 5 years, with a median of -$229000.0 in 2025.
- Across the five-year window, Change in Account Payables surged 1276.81% in 2022 and slumped 1186.96% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$735000.0 in 2022, then jumped by 225.03% to $919000.0 in 2023, then tumbled by 148.75% to -$448000.0 in 2024, then surged by 388.62% to $1.3 million in 2025, then plunged by 196.13% to -$1.2 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$1.2 million in Q1 2026, $1.3 million in Q4 2025, and -$22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | -1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.24 Mn |
| Mar 31, 2026 | -1.24 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | -22,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -229,000.00 |
| Jun 30, 2025 | -229,000.00 |
| Mar 31, 2025 | -592,000.00 |
| Mar 31, 2025 | -592,000.00 |
| Dec 31, 2024 | -448,000.00 |
| Dec 31, 2024 | -448,000.00 |
| Sep 30, 2024 | -1.14 Mn |
| Sep 30, 2024 | -1.14 Mn |
| Jun 30, 2024 | -444,000.00 |
| Jun 30, 2024 | -444,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Dec 31, 2023 | 919,000.00 |
| Dec 31, 2023 | 919,000.00 |